Pilot Trial of Transnasal Nicotine in Parkinson Disease
NCT03865121
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY)
Sponsor
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
Collaborators
[object Object]